Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
283 |
|
| Actual shortage: | 7 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 16 (6%) | |
| Resolved: | 260 (92%) | |
Discontinuation Reports |
50 |
|
| To be discontinued: | 6 (12%) | |
| Discontinued: | 44 (88%) | |
| Reversed: | 0 (0%) | |
Late reports |
21 (6%) |
|
Overdue reports |
4 (31%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| GLUCOPHAGE | 500MG | TABLET | Resolved | 2023-07-19 | 2023-09-01 | 199227 |
| GLUCOPHAGE | 850MG | TABLET | Resolved | 2019-02-20 | 2019-07-19 | 76402 |
| GLUCOPHAGE | 850MG | TABLET | Resolved | 2022-01-21 | 2022-03-30 | 153372 |
| GLUCOPHAGE | 850MG | TABLET | Resolved | 2022-12-14 | 2023-09-01 | 178385 |
| IMOVANE | 5.0MG | TABLET | Resolved | 2018-04-10 | 2019-03-08 | 45394 |
| IMOVANE | 7.5MG | TABLET | Resolved | 2018-12-06 | 2019-02-15 | 68864 |
| JEVTANA | 40MG | SOLUTION | Avoided shortage | 2019-06-27 | 2019-07-19 | 87765 |
| KAYEXALATE | 100% | POWDER | Resolved | 2019-01-15 | 2019-02-06 | 72245 |
| KAYEXALATE | 100% | POWDER | Resolved | 2019-04-23 | 2019-05-24 | 82271 |
| KEVZARA | 200MG | SOLUTION | Resolved | 2022-11-08 | 2022-12-04 | 173986 |
| KEVZARA | 200MG | SOLUTION | Resolved | 2023-03-31 | 2023-04-04 | 188465 |
| KEVZARA | 150MG | SOLUTION | Resolved | 2022-04-22 | 2022-08-26 | 159316 |
| KEVZARA | 150MG | SOLUTION | Resolved | 2023-01-18 | 2023-03-15 | 181429 |
| KEVZARA | 150MG | SOLUTION | Resolved | 2023-04-12 | 2023-08-16 | 189382 |
| KEVZARA | 200MG | SOLUTION | Resolved | 2020-02-21 | 2022-07-20 | 106826 |
| KEVZARA | 200MG | SOLUTION | Resolved | 2022-03-01 | 2022-05-31 | 155759 |
| KEVZARA | 200MG | SOLUTION | Resolved | 2022-11-17 | 2023-02-11 | 175209 |
| LANTUS | 100UNIT | SOLUTION | Resolved | 2021-05-03 | 2021-05-11 | 138648 |
| LANTUS | 100UNIT | SOLUTION | Resolved | 2022-02-02 | 2022-09-14 | 154110 |
| LANTUS | 100UNIT | SOLUTION | Avoided shortage | 2021-04-22 | 2021-05-10 | 137925 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ADLYXINE | 0.05MG 0.1MG | SOLUTION KIT | Discontinued | 2019-02-15 | 2019-02-15 | 75803 |
| ADLYXINE | 10MCG | SOLUTION | Discontinued | 2023-05-15 | 2023-05-16 | 192514 |
| ADLYXINE | 20MCG | SOLUTION | Discontinued | 2023-06-07 | 2023-09-19 | 193877 |
| AMARYL | 4MG | TABLET | Discontinued | 2018-06-04 | 2018-06-12 | 51269 |
| AMARYL | 1MG | TABLET | Discontinued | 2018-06-05 | 2018-09-07 | 51376 |
| AMARYL | 2MG | TABLET | Discontinued | 2018-06-05 | 2018-09-07 | 51379 |
| ARAVA | 100MG | TABLET | Discontinued | 2023-07-10 | 2023-07-11 | 198056 |
| ATROVENT NASAL SPRAY | 21MCG | SOLUTION | Discontinued | 2018-10-17 | 2018-10-17 | 64493 |
| ATROVENT NASAL SPRAY | 42MCG | SOLUTION | Discontinued | 2018-10-17 | 2020-07-27 | 64496 |
| AUBAGIO | 14MG | TABLET | To be discontinued | 2024-05-02 | 2024-05-02 | 226847 |
| CLAFORAN - PWS INJ 1.0G/VIAL | 1G | POWDER FOR SOLUTION | Discontinued | 2017-03-16 | 2017-05-02 | 3103 |
| CLAFORAN - PWS INJ 2.0G/VIAL | 2G | POWDER FOR SOLUTION | Discontinued | 2017-03-20 | 2017-04-05 | 3685 |
| CLOMID | 50MG | TABLET | Discontinued | 2017-03-22 | 2017-03-22 | 3917 |
| CONDYLINE | 0.5% | SOLUTION | To be discontinued | 2021-07-13 | 2021-07-13 | 142368 |
| DEMEROL | 50MG | TABLET | Discontinued | 2019-11-11 | 2020-07-29 | 98380 |
| DIABETA | 2.5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100935 |
| DIABETA | 5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100938 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57608 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57613 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57616 |